AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6

Brendan Gongol1, Traci Marin, I-Chen Peng

  • 1Biochemistry and Molecular Biology Graduate Program, and Division of Biomedical Sciences, University of California, Riverside, CA 92521-0121, USA.

Insights

AMP-activated protein kinase (AMPK) activation triggers the dissociation of Poly [ADP ribose] polymerase 1 (PARP-1) from the Bcl-6 intron 1. This process enhances B-cell lymphoma-6 protein (Bcl-6) expression, reducing endothelial inflammation.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • B-cell lymphoma-6 protein (Bcl-6) acts as a corepressor for inflammatory mediators involved in monocyte recruitment.
  • Poly [ADP ribose] polymerase 1 (PARP-1) promotes inflammation by suppressing Bcl-6 expression through binding to its intron 1.

Purpose of the Study:

  • To investigate the mechanism by which Poly [ADP ribose] polymerase 1 (PARP-1) dissociates from the Bcl-6 intron 1.
  • To elucidate the role of AMP-activated protein kinase (AMPK) in regulating this dissociation and its impact on endothelial inflammation.

Main Methods:

  • Analysis of Poly [ADP ribose] polymerase 1 (PARP-1) primary sequence to identify potential phosphorylation sites.
  • Treatment with AMP-activated protein kinase (AMPK) activators (5-aminoimidazole-4-carboxamide ribonucleotide, metformin, pulsatile shear stress) and inhibitors.
  • Assessment of Poly [ADP ribose] polymerase 1 (PARP-1) binding to Bcl-6 intron 1, Bcl-6 expression, and inflammatory mediator expression.

Main Results:

  • AMPK activation by various stimuli promotes the dissociation of Poly [ADP ribose] polymerase 1 (PARP-1) from the Bcl-6 intron 1.
  • This dissociation leads to increased B-cell lymphoma-6 protein (Bcl-6) expression.
  • AMPK activation and subsequent Bcl-6 upregulation inhibit the expression of key inflammatory mediators, reducing endothelial inflammation.

Conclusions:

  • AMP-activated protein kinase (AMPK) phosphorylation of Poly [ADP ribose] polymerase 1 (PARP-1) at Serine 177 is crucial for its dissociation from the Bcl-6 intron 1.
  • A novel anti-inflammatory pathway involving AMPK, PARP-1, and Bcl-6 in endothelial cells has been identified.
  • Targeting this pathway holds potential for therapeutic interventions in inflammatory conditions.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...